Wuerzner G - Search Results

1

The differential impact of a 6-versus 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS study.

Bandiera C, Dotta-Celio J, Locatelli I, Nobre D, Wuerzner G, Pruijm M, Lamine F, Burnier M, Zanchi A, Schneider MP. Bandiera C, et al. Among authors: wuerzner g. Front Pharmacol. 2024 Jan 24;15:1294436. doi: 10.3389/fphar.2024.1294436. eCollection 2024. Front Pharmacol. 2024. PMID: 38327981 Free PMC article.

2

Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress.

Wuerzner G, Chioléro A, Maillard M, Nussberger J, Brunner HR, Burnier M. Wuerzner G, et al. Kidney Int. 2004 Jan;65(1):238-44. doi: 10.1111/j.1523-1755.2004.00376.x. Kidney Int. 2004. PMID: 14675055 Free article. Clinical Trial.

3

Metoprolol prevents sodium retention induced by lower body negative pressure in healthy men.

Wuerzner G, Chiolero A, Maillard M, Nussberger J, Burnier M. Wuerzner G, et al. Kidney Int. 2005 Aug;68(2):688-94. doi: 10.1111/j.1523-1755.2005.00447.x. Kidney Int. 2005. PMID: 16014046 Free article. Clinical Trial.

4

Effects of selective angiotensin II and beta1-receptor blockade on renal haemodynamics and sodium handling during orthostatic stress in healthy individuals.

Wuerzner G, Burnier M. Wuerzner G, et al. J Hypertens Suppl. 2006 Mar;24(1):S89-93. doi: 10.1097/01.hjh.0000220412.14859.3b. J Hypertens Suppl. 2006. PMID: 16601579 Review.

5

Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring.

Santschi V, Wuerzner G, Schneider MP, Bugnon O, Burnier M. Santschi V, et al. Among authors: wuerzner g. Eur J Clin Pharmacol. 2007 Dec;63(12):1179-84. doi: 10.1007/s00228-007-0364-7. Epub 2007 Sep 25. Eur J Clin Pharmacol. 2007. PMID: 17899047 Clinical Trial.

6

[Treatment of secondary hyperparathyroidism in dialysis: Report of a case-study of treatment failure].

Pruijm MT, Teta D, Wuerzner G, Santschi V, Burnier M. Pruijm MT, et al. Among authors: wuerzner g. Nephrol Ther. 2008 Feb;4(1):28-33. doi: 10.1016/j.nephro.2007.10.001. Nephrol Ther. 2008. PMID: 18088578 French.

7

Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?

Burnier M, Pruijm M, Wuerzner G. Burnier M, et al. Among authors: wuerzner g. Expert Opin Drug Metab Toxicol. 2009 Aug;5(8):981-7. doi: 10.1517/17425250903085135. Expert Opin Drug Metab Toxicol. 2009. PMID: 19619074 Review.

8

Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region.

Pruijm M, Wuerzner G, Maillard M, Bovet P, Renaud C, Bochud M, Burnier M. Pruijm M, et al. Among authors: wuerzner g. Nephrol Dial Transplant. 2010 Jul;25(7):2225-31. doi: 10.1093/ndt/gfq008. Epub 2010 Feb 1. Nephrol Dial Transplant. 2010. PMID: 20124214

9

Effect of sodium loading/depletion on renal oxygenation in young normotensive and hypertensive men.

Pruijm M, Hofmann L, Maillard M, Tremblay S, Glatz N, Wuerzner G, Burnier M, Vogt B. Pruijm M, et al. Among authors: wuerzner g. Hypertension. 2010 May;55(5):1116-22. doi: 10.1161/HYPERTENSIONAHA.109.149682. Epub 2010 Mar 22. Hypertension. 2010. PMID: 20308608

10

Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population.

Wuerzner G, Pruijm M, Maillard M, Bovet P, Renaud C, Burnier M, Bochud M. Wuerzner G, et al. Am J Kidney Dis. 2010 Aug;56(2):303-12. doi: 10.1053/j.ajkd.2010.03.017. Epub 2010 Jun 9. Am J Kidney Dis. 2010. PMID: 20538392

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters